Evidence map›Paper›PMID 26520775›Full record

ArticleNeuroImage2016

The impact of quality assurance assessment on diffusion tensor imaging outcomes in a large-scale population-based cohort.

David R Roalf, Megan Quarmley, Mark A Elliott, Theodore D Satterthwaite, Simon N Vandekar, Kosha Ruparel, Efstathios D Gennatas, Monica E Calkins, Tyler M Moore, Ryan Hopson and 6 more

Abstract read
In one paragraph

Article in NeuroImage, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed, 2 pooled it
17.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 2 syntheses or guidelines pooled it, 231 citations in OpenAlex.

  1. Pooled it
  2. A quantitative meta-analysis of olfactory dysfunction in mild cognitive impairment.Journal of neurology, neurosurgery, and psychiatry · 2017
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

David R RoalfNeuropsychiatry Section, Department of Psychiatry, USA. Electronic address: roalf@upenn.edu.
Megan QuarmleyNeuropsychiatry Section, Department of Psychiatry, USA.
Mark A ElliottDepartment of Radiology, University of Pennsylvania, Perelman School of Medicine, USA.
Theodore D SatterthwaiteNeuropsychiatry Section, Department of Psychiatry, USA.
Simon N VandekarNeuropsychiatry Section, Department of Psychiatry, USA; Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Kosha RuparelNeuropsychiatry Section, Department of Psychiatry, USA.
Efstathios D GennatasNeuropsychiatry Section, Department of Psychiatry, USA.
Monica E CalkinsNeuropsychiatry Section, Department of Psychiatry, USA.
Tyler M MooreNeuropsychiatry Section, Department of Psychiatry, USA.
Ryan HopsonNeuropsychiatry Section, Department of Psychiatry, USA.
Karthik PrabhakaranNeuropsychiatry Section, Department of Psychiatry, USA.
Chad T JacksonNeuropsychiatry Section, Department of Psychiatry, USA.
Ragini VermaDepartment of Radiology, University of Pennsylvania, Perelman School of Medicine, USA; Section of Biomedical Image Analysis, University of Pennsylvania, USA.
Hakon HakonarsonCenter for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Ruben C GurNeuropsychiatry Section, Department of Psychiatry, USA; Department of Radiology, University of Pennsylvania, Perelman School of Medicine, USA.
Raquel E GurNeuropsychiatry Section, Department of Psychiatry, USA; Department of Radiology, University of Pennsylvania, Perelman School of Medicine, USA.
University of Pennsylvania · USChildren's Hospital of Philadelphia · US

Funding

Neurodevelopmental Genomics: Trajectories of Complex PhenotypesRC2MH089983 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E · 2009 to 2011
$14.3M
2/2 Neurodevelopmental Genomics: Trajectories of Complex PhenotypesRC2MH089924 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI HAKONARSON, HAKON · 2009 to 2011
$10.7M
NMDA Receptor Hypofunction in the Amygdala of Schizophrenia PatientsP50MH096891 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BILKER, WARREN B. · 2012 to 2016
$10.6M
Longitudinal multi-modal neuroimaging of irritability in youthR01MH107703 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI SATTERTHWAITE, THEODORE · 2015 to 2018
$2.6M
Multimodal brain maturation indices modulating psychopathology and neurocognitionR01MH107235 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RUBEN C. · 2015 to 2017
$1.5M
Mental Health Biostatistics Training ProgramT32MH065218 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BILKER, WARREN B. · 2003 to 2018
$1.3M
Neuroimaging of Dimensional Reward Dysfunction in AdolescenceK23MH098130 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI SATTERTHWAITE, THEODORE · 2012 to 2015
$723k
Neurocognitive variability in schizophrenia and youth at-risk for psychosisK01MH102609 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI ROALF, DAVID R · 2014 to 2017
$685k
NIMH NIH HHS K01 MH102609NIMH NIH HHS K01MH102609NIMH NIH HHS K23 MH098130NIMH NIH HHS K23MH098130NIMH NIH HHS MH089924NIMH NIH HHS MH089983NIMH NIH HHS P50 MH096891NIMH NIH HHS P50MH096891NIMH NIH HHS R01 MH107235NIMH NIH HHS R01 MH107703NIMH NIH HHS R01MH107703NIMH NIH HHS RC2 MH089924NIMH NIH HHS RC2 MH089983NIMH NIH HHS T32 MH065218NIMH NIH HHS T32MH065218-11
6 · The paper itself

Abstract

backgroundDiffusion tensor imaging (DTI) is applied in investigation of brain biomarkers for neurodevelopmental and neurodegenerative disorders. However, the quality of DTI measurements, like other neuroimaging techniques, is susceptible to several confounding factors (e.g., motion, eddy currents), which have only recently come under scrutiny. These confounds are especially relevant in adolescent samples where data quality may be compromised in ways that confound interpretation of maturation parameters. The current study aims to leverage DTI data from the Philadelphia Neurodevelopmental Cohort (PNC), a sample of 1601 youths with ages of 8-21 who underwent neuroimaging, to: 1) establish quality assurance (QA) metrics for the automatic identification of poor DTI image quality; 2) examine the performance of these QA measures in an external validation sample; 3) document the influence of data quality on developmental patterns of typical DTI metrics.

methodsAll diffusion-weighted images were acquired on the same scanner. Visual QA was performed on all subjects completing DTI; images were manually categorized as Poor, Good, or Excellent. Four image quality metrics were automatically computed and used to predict manual QA status: Mean voxel intensity outlier count (MEANVOX), Maximum voxel intensity outlier count (MAXVOX), mean relative motion (MOTION) and temporal signal-to-noise ratio (TSNR). Classification accuracy for each metric was calculated as the area under the receiver-operating characteristic curve (AUC). A threshold was generated for each measure that best differentiated visual QA status and applied in a validation sample. The effects of data quality on sensitivity to expected age effects in this developmental sample were then investigated using the traditional MRI diffusion metrics: fractional anisotropy (FA) and mean diffusivity (MD). Finally, our method of QA is compared with DTIPrep.

resultsTSNR (AUC=0.94) best differentiated Poor data from Good and Excellent data. MAXVOX (AUC=0.88) best differentiated Good from Excellent DTI data. At the optimal threshold, 88% of Poor data and 91% Good/Excellent data were correctly identified. Use of these thresholds on a validation dataset (n=374) indicated high accuracy. In the validation sample 83% of Poor data and 94% of Excellent data was identified using thresholds derived from the training sample. Both FA and MD were affected by the inclusion of poor data in an analysis of an age, sex and race matched comparison sample. In addition, we show that the inclusion of poor data results in significant attenuation of the correlation between diffusion metrics (FA and MD) and age during a critical neurodevelopmental period. We find higher correspondence between our QA method and DTIPrep for Poor data, but we find our method to be more robust for apparently high-quality images.

conclusionAutomated QA of DTI can facilitate large-scale, high-throughput quality assurance by reliably identifying both scanner and subject induced imaging artifacts. The results present a practical example of the confounding effects of artifacts on DTI analysis in a large population-based sample, and suggest that estimates of data quality should not only be reported but also accounted for in data analysis, especially in studies of development.

Indexed as

AdolescentArea Under CurveChildCohort StudiesDiffusion Tensor ImagingFemaleHumansImage Interpretation, Computer-AssistedMaleNeuroimagingQuality Assurance, Health CareROC CurveYoung AdultAdolescenceAutomated quality assuranceBrain maturationDiffusion tensor imagingMotion

Identifiers

PMID26520775
PMCPMC4753778
OpenAlexW2211147350

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.